EUVIMEDEUVIMED entdecken
Crossref

Drug Property Optimization: Design, Synthesis, and Characterization of Novel Pharmaceutical Salts and Cocrystal-Salt of Lumefantrine

Bolaji C Dayo Owoyemi iD, Matthias Zeller iD, Brenda Pereira da Silva, Amos O Akinyemi, Romulo A Ando iD, Gabriel L Barros de Araujo iD, Stephen R Byrn

Molecular Pharmaceutics · 03.02.2025 · 22 (2) · 1042-1060

DOI: 10.1021/acs.molpharmaceut.4c01244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 13.01.2025. Verfasst von Bolaji C Dayo Owoyemi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Science, University of São Paulo - USP, Av. Professor Lineu Prestes, 580 - Cidade Universitária São Paulo, São Paulo CEP…. Hauptthemen laut MEDLINE: Antimalarials, Fluorenes, Ethanolamines. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Division of Chemistry, Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lumefantrine (LMF) is a low-solubility antimalarial drug that cures acute, uncomplicated malaria. It exerts its pharmacological effects against erythrocytic stages of Plasmodium spp. and prevents malaria pathogens from producing nucleic acid and protein, thereby eliminating the parasites. Modifying the structure of a drug through the formation of a pharmaceutical cocrystal or salt presents an avenue through which its physicochemical properties can be optimized. In this work, we report the design/synthesis and solid-state characterization of four new salts and cocrystal-salt forms of LMF; an LMF–ADP salt, monoclinic space group P2 1 /n; an LMF–FUM cocrystal-salt, monoclinic space group P2 1 /c; an LMF–TAR solvate salt, monoclinic space group P2 1 /n; and an LMF–SUC salt, triclinic, space group P1̅ (ADP, dianion of adipic acid; FUM, monoanion of fumaric acid; TAR, dianion of tartaric acid; SUC, dianion of succinic acid). These salts can be obtained by solution as well as by mechanochemical cocrystallization methods. The multicomponent systems gain their stability from hydrogen and partial ionic bonding interactions (N–H···O, O–H···O, N + –H···O –, and O–H + ···O – ) originating from both the dibutyl ammonium (N + –H) site and the alcohol hydroxyl (−OH) site of LMF toward the carboxylate (−C(O – )═O) functional groups of the coformer anions. SCXRD indicates for LMF–ADP, LMF–TAR, and LMF–SUC complete transfer of all carboxylic acid protons (H + ) toward the LMF nitrogen, while for LMF–FUM, one of the protons is transferred (leaving a hydrofumarate monoanion). Using salicylic and acetylsalicylic acids as coformers yielded coamorphous solids. Solid-state characterization using powder X-ray diffraction (XRD) and thermal techniques (DSC and TGA) support and confirm the structures obtained from single-crystal XRD. LMF–ADP and LMF–FUM present superior stability under standard conditions (40 ± 2 °C, 75 ± 5% RH, and 3 months) compared to the amorphous samples and the other two salts. LMF–SUC showed poor thermal stability by DSC/TGA, and powder XRD patterns for LMF–TAR showed substantial change after the 3-month stability test. Finally, the calculated equilibrium solubilities for the cocrystal salts indicate an increase of more than twofold compared to LMF’s solubility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsFluorenesEthanolaminesCrystallizationLumefantrineSaltsDrug DesignSolubilityCrystallography, X-RayFumaratesTartratesX-Ray Diffraction

Stichwörter der Autor:innen

X-ray diffractionantimalariacocrystalhydrogen bondinglumefantrinesaltsolubility

Substanzen

AntimalarialsLumefantrineSaltsFluorenesEthanolaminesFumaratestartaric acidfumaric acidTartrates

Autor:innen und Institutionen

  • Department of Pharmaceutical Science, University of São Paulo - USP, Av. Professor Lineu Prestes, 580 - Cidade Universitária São Paulo, São Paulo CEP 05508-000, Brazil.
  • Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, Indiana 47907, United States.
  • Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, United States.
  • Department of Toxicology and Cancer Biology, University of Kentucky, Lexington 40536-0298, United States.
  • Institute of Chemistry, University of São Paulo - USP, Av. Professor Lineu Prestes, 748 - Cidade Universitária São Paulo, São Paulo CEP 05508-000, Brazil.

ORCID-Profile: Bolaji C Dayo Owoyemi, Matthias Zeller, Romulo A Ando, Gabriel L Barros de Araujo

Förderung

  • Division of Chemistry
  • Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo

Zitieren

APA

Dayo Owoyemi, B. C., Zeller, M., Pereira da Silva, B., Akinyemi, A. O., Ando, R. A., de Araujo, G. L. B., & Byrn, S. R. (2025). Drug Property Optimization: Design, Synthesis, and Characterization of Novel Pharmaceutical Salts and Cocrystal-Salt of Lumefantrine. Molecular Pharmaceutics, 22(2), 1042-1060. https://doi.org/10.1021/acs.molpharmaceut.4c01244

Vancouver

Dayo Owoyemi BC, Zeller M, Pereira da Silva B, Akinyemi AO, Ando RA, de Araujo GLB, et al. Drug Property Optimization: Design, Synthesis, and Characterization of Novel Pharmaceutical Salts and Cocrystal-Salt of Lumefantrine. Molecular Pharmaceutics. 2025;22(2):1042-1060. doi:10.1021/acs.molpharmaceut.4c01244

BibTeX
@article{DayoOwoyemi2025,
  author = {Dayo Owoyemi, Bolaji C and Zeller, Matthias and Pereira da Silva, Brenda and Akinyemi, Amos O and Ando, Romulo A and de Araujo, Gabriel L Barros and Byrn, Stephen R},
  title = {Drug Property Optimization: Design, Synthesis, and Characterization of Novel Pharmaceutical Salts and Cocrystal-Salt of Lumefantrine},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  volume = {22},
  number = {2},
  pages = {1042--1060},
  doi = {10.1021/acs.molpharmaceut.4c01244}
}
Kostenlos starten →